Belimumab Reduces the Frequency of Flares in Patients with Refractory SLE: DATA from Clinical Practice Setting

被引：0
|
作者：
Doria, Andrea [1 ]
Iaccarino, Luca [1 ]
Bettio, Silvano [1 ]
Frassi, Micol [2 ,3 ]
Andreoli, Laura [2 ,3 ]
Reggia, Rossella [2 ,3 ]
Zen, Margherita [1 ]
Nalotto, Linda [1 ]
Gatto, Mariele [1 ]
Pea, Lara [2 ,3 ]
Punzi, Leonardo [1 ]
Tincani, Angela [2 ,3 ]
机构：
[1] Univ Padua, Padua, Italy
[2] Spedali Civil Brescia, I-25125 Brescia, Italy
[3] Univ Brescia, Brescia, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
671
引用
收藏
页码：S292 / S293
页数：2
相关论文
共 50 条
  • [31] 24-MONTH OUTCOMES ASSOCIATED WITH BELIMUMAB IN HISPANIC PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN A CLINICAL PRACTICE SETTING IN THE UNITED STATES
    Collins, Christopher E.
    Kerr, Gail
    Von Feldt, Joan
    Rubin, Bernie
    Katz, Arie
    Chung, Jake
    Huang, Shirley
    Bell, Christopher F.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 112 - 112
  • [32] PHARMACOKINETICS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Sheikh, S. Z.
    Fox, N. L.
    Hammer, A. E.
    Struemper, H.
    Groark, J.
    Roth, D.
    Gordon, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 297 - 298
  • [33] Optimal assessment and monitoring of SLE patients in clinical practice
    Voskuyl, Alexandre
    LUPUS SCIENCE & MEDICINE, 2020, 7 (SUPPL_2): : A13 - A14
  • [34] Evolution of Patients with Systemic Lupus Erythematous Treated with Belimumab in Clinical Practice Settings
    Cortes, Josefina
    Marras, Carlos
    Luis Andreu, Jose
    Calvo-Alen, Jaime
    Garcia-Aparicio, Angel M.
    Diez Alvarez, Elvira
    Coronell, Carlos
    Morejon, Elena
    Perna, Alessandra
    Koscielny, Volker
    Ordi-Ros, Josep
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S291 - S292
  • [35] REDUCTION OF DISEASE ACTIVITY, FLARES, AND STEROID USE BY BELIMUMAB, A BLyS-SPECIFIC INHIBITOR, IN PATIENTS WITH SEROPOSITIVE SLE: BLISS-52 STUDY
    Gallacher, A.
    Guzman, R.
    Leon, M. G.
    Levy, R. A.
    Radominski, S.
    Jimenez, R.
    Spindler, A.
    Scotton, A.
    Jaller, J.
    Pineda, L.
    Jhong, Z. J.
    Freimuth, W.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S62 - S63
  • [36] IMPACT OF BELIMUMAB USE ON FLARES AMONG PATIENTS DIAGNOSED WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN A US COMMERCIALLY INSURED DATABASE: 2010-2014
    Stott-Miller, M.
    Egger, P.
    Eudy, A.
    Maskell, J.
    Fu, Q.
    Kan, H.
    Alfonso-Cristancho, R.
    Costenbader, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 68 - 68
  • [37] Efficacy of tolvaptan in patients with refractory ascites in a clinical setting
    Takamasa Ohki
    Koki Sato
    Tomoharu Yamada
    Mari Yamagami
    Daisaku Ito
    Koki Kawanishi
    Kentaro Kojima
    Michiharu Seki
    Nobuo Toda
    Kazumi Tagawa
    World Journal of Hepatology, 2015, (12) : 1685 - 1693
  • [38] Efficacy of tolvaptan in patients with refractory ascites in a clinical setting
    Ohki, Takamasa
    Sato, Koki
    Yamada, Tomoharu
    Yamagami, Mari
    Ito, Daisaku
    Kawanishi, Koki
    Kojima, Kentaro
    Seki, Michiharu
    Toda, Nobuo
    Tagawa, Kazumi
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (12) : 1685 - 1693
  • [39] SLE FLARES FROM THE PATIENT PERSPECTIVE: WHAT PATIENTS DISCUSS IN AN INTERNET FORUM
    Shiozawa, A.
    Katic, B.
    Simacek, K.
    Curran, C.
    Merikle, E.
    VALUE IN HEALTH, 2016, 19 (03) : A252 - A252
  • [40] Dosage and frequency of infliximab in clinical practice: Data from the sture registry
    Van Vollenhoven, RF
    Klareskog, L
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 253 - 253
12345